Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)
China · Delayed Price · Currency is CNY 80.00
-1.68 (-2.06%)
Oct 16, 2026, 3:04 PM CST
SHE:300436 Revenue
Fujian Cosunter Pharmaceutical had revenue of 121.71M CNY in the quarter ending June 30, 2026, with 9.40% growth. This brings the company's revenue in the last twelve months to 427.67M, down -1.03% year-over-year. In the year 2025, Fujian Cosunter Pharmaceutical had annual revenue of 416.37M, down -5.68%. That makes Fujian Cosunter Pharmaceutical the 26,090th largest company in the world by revenue and 4,611th in China.
Revenue (ttm)
427.67M
Revenue Growth
-1.03%
P/S Ratio
31.43
Revenue / Employee
n/a
Employees
715
Market Cap
13.44B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 416.37M | -25.08M | -5.68% |
| Dec 31, 2024 | 441.46M | 18.74M | 4.43% |
| Dec 31, 2023 | 422.71M | 36.95M | 9.58% |
| Dec 31, 2022 | 385.77M | 15.32M | 4.14% |
| Jan 1, 2022 | 370.44M | 1.95M | 0.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.